What is the main business of BVS Genetics?

The main business activity of BVS Genetics focuses on support activities for animal production.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 30, 2022.

Where is the headquarters located?

The headquarters is located at: 34A, 08-300 Kosierady Wielkie.

Who is on the management board?

The management board consists of: Mateusz Krystian Skup (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $947,829 in 2025, which is an increase of 24.6% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $317,938, meaning the company increased its profit by 42.2%.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $242,087 in 2025, representing 41% of all operating expenses.

BVS Geneticssp. z o.o.

Support activities for animal production

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-12-30

Share capital

100 000,00 PLN

Activity description

BVS Genetics, operating under the Bovisvet brand, runs a veterinary clinic. The company also operates an In Vitro Centre.

Registered address

34A, 08-300 Kosierady Wielkie, Poland

Website

bovisvet.com

Financials

Revenue history (in k)

Financial insight

companies.financials.estonianCitCertain

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 947.83kMedianUSD 200.62kAverageUSD 2.70m

Net profit

This companyUSD 317.94kMedianUSD 1.00kAverageUSD 168.27k

Operating costs

This companyUSD 591.14kMedianUSD 196.27kAverageUSD 2.49m

Assets

This companyUSD 1.22mMedianUSD 86.50kAverageUSD 2.23m

Industry

Bank accounts

Registered as a VAT taxpayer on 2023-01-09. Active

Alior Bank
46 2490 0005 0000 4612 5771 8864
Alior Bank
47 2490 1057 0000 9901 7690 6707
Alior Bank
87 2490 0005 0000 4530 7881 5381

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Mateusz Krystian Skup – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Piotr Mirosław Skup (42)	950	$25,661.80	95%
Others	50	$1,350.62	5%

The articles of association require board approval for share transfers.

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Agencja Inwestycyjno - Handlowa B&Bsp. z o.o.	$2,495,960.20	bbtl.pl
Granotecsp. z o.o.	$1,169,087.51	granotec.pl
Biodragonsp. z o.o.	$828,681.15	biodragon.pl
FARM InnovationsS.A.	$562,954.20	farminnovations.pl
Biotrials BaranowskaS.K.A.	$222,905.55	biotrials.pl

Change history

Date	Event
2023-04-06	PKD change (Added: 46.21.Z, 46.23.Z, 46.61.Z)
2022-12-30	Entered in the register

FAQ

Last updated: 2026-07-16